by goodpep | Jun 30, 2023 | Articles
To facilitate continued access to buprenorphine for opioid use disorder (OUD) during the COVID-19 pandemic, the US federal government allowed clinicians to initiate buprenorphine remotely, without in-person examinations. This study assessed trends before and during...
by goodpep | Jun 30, 2023 | Articles
This study investigated whether the gap between the number of persons with opioid use disorder (OUD) and the number who receive medications for opioid use disorder (MOUD) has narrowed over the last decade in the US. Researchers adjusted data from the National Survey...
by goodpep | Jun 30, 2023 | Articles
Individuals with opioid use disorder (OUD) make up 15–20 percent of incarcerated populations in the US, and are at risk of overdose upon release. While incarcerated, many people with OUD are not provided medication for OUD (MOUD; e.g., methadone or buprenorphine)....
by goodpep | Jun 30, 2023 | Articles
Researchers conducted a cross-sectional assessment of deaths due to excessive alcohol consumption among US adults aged 20–64 years. Using national mortality data from 2015 through 2019, the authors estimated mean annual deaths directly attributable to alcohol...
by goodpep | Jun 30, 2023 | Articles
While cannabis products remain illegal in the US by federal law, most states have laws that allow people to use cannabis for “medical” or non-medical purposes. This study used the National Poison Data System to examine trends in cannabis ingestion among children <6...
by goodpep | Jun 30, 2023 | Articles
Up to a quarter of US high school students use nicotine products in a given month; multiple product use is associated with higher levels of nicotine dependence,* which negatively impacts cessation efforts. This study used data from the Population Assessment of Tobacco...
